Enveric Biosciences (ENVB) Insider Trading & Ownership $1.73 +0.09 (+5.49%) Closing price 03/14/2025 04:00 PM EasternExtended Trading$1.76 +0.03 (+1.73%) As of 03/14/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Enveric Biosciences (NASDAQ:ENVB) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage3.20%Number OfInsiders Buying(Last 3 Years)1Amount OfInsider Buying(Last 3 Years)$2,118.60Number OfInsiders Selling(Last 3 Years)0 Get ENVB Insider Trade Alerts Want to know when executives and insiders are buying or selling Enveric Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENVB Insider Buying and Selling by Quarter Remove Ads Enveric Biosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/15/2023Frank PasqualoneDirectorBuy66$32.10$2,118.60 (Data available from 1/1/2013 forward) ENVB Insider Trading Activity - Frequently Asked Questions Who is on Enveric Biosciences's Insider Roster? The list of insiders at Enveric Biosciences includes Frank Pasqualone. Learn more on insiders at ENVB. What percentage of Enveric Biosciences stock is owned by insiders? 3.20% of Enveric Biosciences stock is owned by insiders. Learn more on ENVB's insider holdings. Which Enveric Biosciences insiders have been buying company stock? The following insider purchased ENVB shares in the last 24 months: Frank Pasqualone ($2,118.60). How much insider buying is happening at Enveric Biosciences? Insiders have purchased a total of 66 ENVB shares in the last 24 months for a total of $2,118.60 bought. Enveric Biosciences Key ExecutivesDr. Joseph Edward Tucker Ph.D. (Age 55)CEO & Director Compensation: $450.79kMr. Kevin M. Coveney CPA (Age 60)Chief Financial Officer Compensation: $385.62kDr. Peter J. Facchini Ph.D. (Age 60)Chief Innovation Officer Compensation: $233.27k More Insider Trading Tools from MarketBeat Related Companies KZIA Insider Trades ADIL Insider Trades CERO Insider Trades SONN Insider Trades SNPX Insider Trades CDT Insider Trades ALZN Insider Trades ATNF Insider Trades AWH Insider Trades OGEN Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles SentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are Buying This page (NASDAQ:ENVB) was last updated on 3/17/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.